Skip to main content
Contact Us
Subscribe
E-Edition
89°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Phase 2 Trial
Recent news which mentions Phase 2 Trial
< Previous
1
2
3
4
5
6
7
8
9
Next >
Clene Nanomedicine Presents Updated Data From Mid-Stage Amyotrophic Lateral Sclerosis Trials
March 14, 2022
Tickers
CLNN
Tags
Biotech
News
Market News
From
Benzinga
BridgeBio Pharma Posts Updated Data From Muscular Dystrophy Trial, Plots Path To Market
March 14, 2022
Tickers
BBIO
Tags
Health Care
Trading Ideas
Benzinga
From
Benzinga
Scholar Rock To Highlight Apitegromab Data From Ambulatory Cohort In Muscular Dystrophy
March 14, 2022
Tickers
SRRK
Tags
Market News
Spinal Muscular Atrophy
SRRK
From
Benzinga
Why Sanofi Shares Are Trading Lower Today
March 14, 2022
Tickers
SNY
Tags
General
Briefs
Movers
From
Benzinga
Moderna Starts Dosing In Mid-Stage Omicron-Specific Bivalent Booster Candidate
March 10, 2022
Tickers
MRNA
Tags
COVID/19 Vaccine
Health Care
General
From
Benzinga
FDA Gives Green Signal To Inventiva's Mid-Stage Lanifibranor Study In NASH Patients
March 08, 2022
Tickers
IVA
Tags
IVA
Biotech
News
From
Benzinga
Alkermes' Nemvaleukin Shows Encouraging Anti-Tumor Activity In Pretreated Kidney Cancer
February 17, 2022
Tickers
ALKS
Tags
Biotech
Health Care
renal cell carcinoma
From
Benzinga
Amgen Posts Latest Batch of Lumakras Data In Pancreatic Cancer
February 15, 2022
Tickers
AMGN
Tags
Phase 2 Trial
Pancreatic Cancer
Benzinga
From
Benzinga
ImmunityBio's Ankitva Shows 100% Survival At Two Years In Bladder Cancer Setting
February 15, 2022
Tickers
ENDP
IBRX
MRK
Tags
Phase 2 Trial
Trading Ideas
Benzinga
From
Benzinga
BioXcel BXCL701 Combo Therapy Shows Encouraging Response Rates In Prostate Cancer
February 15, 2022
Tickers
BTAI
MRK
Tags
General
Briefs
Market News
From
Benzinga
Opthea Shares OPT-302 data In Patients With Subtype Of Age-Related Macular Degeneration
February 14, 2022
Tickers
OPT
Tags
Biotech
Age/Related Macular Degeneration
News
From
Benzinga
RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial
February 09, 2022
Tickers
RGNX
Tags
Phase 1 Trial
Small Cap
News
From
Benzinga
4D Molecular Shares Updated Data From Fabry Disease Trial
February 09, 2022
Tickers
FDMT
Tags
Fabry disease
Biotech
FDMT
From
Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
February 09, 2022
Tickers
AVRO
Tags
General
Market News
Phase 1 Trial
From
Benzinga
Why Are NLS Pharmaceutics Shares Trading Higher During Premarket Monday?
February 07, 2022
Tickers
NLSP
Tags
Health Care
Penny Stocks
Phase 2 Trial
From
Benzinga
Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward
February 04, 2022
Tickers
PFE
VALN
Tags
VALN
Biotech
Benzinga
From
Benzinga
Altimmune's Mid-Stage Pemvidutide Study Cleared By FDA For Obesity
January 31, 2022
Tickers
ALT
Tags
Market News
Movers
obesity
From
Benzinga
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target
January 31, 2022
Tickers
JNJ
KLDO
Tags
JNJ
Analyst Ratings
Biotech
From
Benzinga
Taysha Gene Plans Protocol Amendment After Patient Death In Gene Therapy Trial
January 27, 2022
Tickers
TSHA
Tags
Movers
Market News
General
From
Benzinga
4D Pharma's Asthma Candidate Shows Positive Trends In Multiple Secondary Endpoints Of Efficacy
January 27, 2022
Tickers
LBPS
Tags
Phase 1 Trial
News
General
From
Benzinga
Why Are Tyme Technologies Shares Staring At 52-Week Low
January 26, 2022
Tickers
TYME
Tags
News
Phase 3 Trial
Movers
From
Benzinga
Two Organizations To Support Wave Life Sciences' FTD, ALS Program
January 26, 2022
Tickers
WVE
Tags
Phase 2 Trial
Market News
Benzinga
From
Benzinga
Imara To Start Testing Tovinontrine In Heart Failure Patients
January 25, 2022
Tickers
IMRA
Tags
Trading Ideas
Benzinga
Phase 2 Trial
From
Benzinga
FDA Holds Mustang Bio's Gene Therapy IND For Compromised Immune System Disorder
January 25, 2022
Tickers
FBIO
MBIO
Tags
FDA
Benzinga
Phase 2 Trial
From
Benzinga
89bio's NASH Candidate Shows Improvement In Disease Severity, Cardiovascular Health
January 25, 2022
Tickers
ETNB
Tags
News
Phase 1 Trial
Biotech
From
Benzinga
Tango Therapeutics' TNG908 IND For Cancer Study Gets Green Signal By FDA
January 24, 2022
Tickers
TNGX
Tags
News
Small Cap
Phase 1 Trial
From
Benzinga
On Positive Virology Data, SAB Biotherapeutics' COVID-19 Drug To Move To Phase 3 In NIH ACTIV-2 Trial
January 24, 2022
Tickers
SABS
Tags
Phase 3 Trial
News
Biotech
From
Benzinga
MediWound's EscharEx Mid-Stage Trial Meets Primary Goal In Venous Leg Ulcers
January 24, 2022
Tickers
MDWD
Tags
News
Health Care
Penny Stocks
From
Benzinga
Mirati Therapeutics Posts 41% Objective Response Rate In Pretreated GI Cancer Patients
January 21, 2022
Tickers
MRTX
Tags
Biotech
News
Market News
From
Benzinga
Provention Bio Starts Mid-Stage Lupus Trial; Data Expected In 2024
January 21, 2022
Tickers
PRVB
Tags
Biotech
Phase 2 Trial
PRVB
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.